Designing HIV Vaccine Efficacy Trials in the Context of Highly Effective Non-vaccine Prevention Modalities

The evolving HIV prevention landscape poses challenges to the statistical design of future trials of candidate HIV vaccines. Study designs must address the anticipated reduction in HIV incidence due to adding new prevention modalities to the standard prevention package provided to trial participants...

Descripción completa

Detalles Bibliográficos
Autores principales: Janes, Holly, Zhu, Yifan, Brown, Elizabeth R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022814/
https://www.ncbi.nlm.nih.gov/pubmed/36938334
http://dx.doi.org/10.1007/s12561-020-09292-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022814/
https://www.ncbi.nlm.nih.gov/pubmed/36938334
http://dx.doi.org/10.1007/s12561-020-09292-1

Ejemplares similares